News
Targeted Delivery in IPF: Inhalation Therapy
As part of a four-part series, we are looking at targeted delivery in idiopathic pulmonary fibrosis (IPF). This week, we focus on inhalation therapy after
Alderley Analytical and Peak Proteins join the TherapeutAix Network
Following a recent collaboration, TherapeutAix is delighted to announce the addition of Alderley Analytical and Peak Proteins as network partners. TherapeutAix has joined with Alderley
TherapeutAix turns two!
This September, TherapeutAix is two years old. Here, we look back on the past 12 months, and take a sneak peek into the future. Our
COVID-19 and Learning about Lung Fibrosis
Emerging understanding of the clinical course of COVID-19 may enable a better understanding of fibrosis in the lung. Future learnings may eventually be applicable to
Common denominators in fibrotic lung disease
With fibrotic disease being one of our areas of interest, it has been highly interesting to follow the news in the past six months or
2019 Round Up – A Full Year!
With 2019 coming to a close, we’re reflecting on a year filled with activities including: advising clients on their projects, expanding our network, participating in
TherapeutAix to present at the Anti-Fibrotic Drug Development Summit in Boston
We are proud partners for the 3rd Annual Anti-Fibrotic Drug Development Summit (AFDD) which will take place on November 18-20th in Boston. Keynote speakers for